Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/JW-CAYMAN-THERAPEUTICS-CO-119080133/news/JW-Therapeutics-Announces-IND-Approval-for-the-Pivotal-Clinical-Trial-of-Carteyva-in-Second-line-L-39921261/?utm_source=whatsapp&utm_medium=social&utm_campaign=share